No.

Compound name

Structure

Pharmacological effect results

Pa Pi activity

1

N-(β-D-xylopyranosil)-thiosemicarbazide

9 of 321 Possible Toxic and Adverse Effects at Pa > 0.500

0.747 0.010 Hyperuricemia

0.680 0.046 Neuritis

0.664 0.052 Renal insufficiency

0.643 0.031 Acidosis, metabolic

0.628 0.042 Acidosis

0.640 0.067 Anemia, hemolytic

0.640 0.067 Hyperactivity

0.574 0.111 Dysesthesia

0,.512 0.089 Optic neuritis

2

N-(β-D-galactopyranosil)-thiosemicarbazide

23 of 321 Possible Toxic and Adverse Effects at Pa > 0.500

0.818 0.005 Hyperuricemia

0.689 0.039 Diarrhea

0.682 0.047 Renal insufficiency

0.682 0.049 Myocardial ischemia

0.652 0.048 Hypoxia

0.628 0.035 Optic neuritis

0.620 0.042 Psychoses

0.605 0.027 Peripheral neuropathy

0.599 0.046 Optic neuropathy

0,596 0.080 Hyperactivity

0.549 0.051 Ototoxicity

0.679 0.007 Antiviral (Influenza)

0.685 0.029 Antineoplastic

0.628 0.013 Antiviral (Poxvirus)

0.586 0.005 Antidiabetic symptomatic

0.543 0.005 Antiviral

0.564 0.028 Immunostimulant

0,549 0.014 DNA synthesis inhibitor

0.539 0.005 Antioxidant

0.544 0.013 Antibacterial

0.511 0.024 Cytostatic

0.508 0.022 Antidiabetic